News
Dexcom and Nick Jonas Unveil First-Ever Super Bowl Commercial, Calling for Better Care for People With Diabetes
DexCom, Inc. (NASDAQ:DXCM), the global leader in continuous glucose monitoring for people with diabetes, debuted today its first-ever Super Bowl commercial, starring multi-platinum recording
PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2020 RESULTS AND RELEASES 5-YEAR PIPELINE METRICS
Pfizer Inc. (NYSE: PFE) reported financial results for fourth-quarter 2020 and full-year 2020, raised 2021 guidance(4) for Adjusted diluted EPS(2) and provided 2021 financial guidance(4) for other
DispatchHealth and Humana Team Up to Provide Hospital-Level Care in the Home
Humana Inc., a leading health and well-being company, and DispatchHealth, a provider of in-home medical care, today announced an agreement to provide Humana members with access to an advanced level
Agilent Wins Trade Secret and Patent Infringement Litigation
Agilent Technologies Inc. (NYSE: A) today announced it has won a judgement in federal court for patent infringement and trade secret misappropriation against Shanghai-based J&X Technologies. The
Illumina and Sequoia Capital China Partner to Launch Genomics Incubator in China
January 31, 2021—Illumina, Inc. (NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, and Sequoia Capital China, a leading investment firm, today announced a
Quidel to Hold Fiscal Fourth Quarter and Full Year 2020 Financial Results Conference Call on February 18th, 2021
Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will report fiscal fourth quarter and
PerkinElmer Board Declares Quarterly Dividend
The Board of Directors of PerkinElmer, Inc. (NYSE: PKI), declared a regular quarterly dividend of $0.07 per share of common stock January 28, 2021. This dividend is payable on May 7, 2021 to all
Waters Corporation Recognized for Commitment to Diversity and Inclusion by the Human Rights Campaign Foundation
Waters Corporation (NYSE:WAT) today announced that it received a score of 95 out of 100 on the 2021 Corporate Equality Index (CEI), the Human Rights Campaign Foundation’s annual scorecard for LGBTQ
Report: 22 Million U.S. Seniors Lack Broadband Internet Access; First Time Study Quantifies Digital Isolation of Older Americans as Pandemic Continues to Ravage Nation
Older Adults Technology Services, Inc. (OATS), in partnership with the Humana Foundation, today released a new report that for the first time quantifies the size and degree of the digital isolation
Go365® by Humana Announces Winners of Third Annual National Step Challenge, Resulting in 8.6 Billion Steps Taken and One Million Meals Donated to Feeding America®
Today, leading health and well-being company, Humana Inc. (NYSE: HUM), announced the winners of its 2020 Go365 National Step Challenge – a health and wellness contest that focuses on improving the
Waters Otto SPEcialist Positive Pressure Manifold Improves Reproducibility and Reliability of Solid-Phase Extraction (SPE)
Waters Corporation (NYSE:WAT) today introduced the OttoTM SPEcialist Positive Pressure Manifold designed to improve the reliability and reproducibility of solid phase extraction (SPE). Equipped
Pfizer Shares Co-Primary Endpoint Results from Post-Marketing Required Safety Study of XELJANZ® (tofacitinib) in Subjects with Rheumatoid Arthritis (RA)
Pfizer Inc. (NYSE: PFE) announced today co-primary endpoint results from a recently completed post-marketing required safety study, ORAL Surveillance (A3921133; NCT02092467). The primary objective
Agilent to Webcast First-Quarter Fiscal Year 2021 Financial Results Presentation
Agilent Technologies Inc. (NYSE: A) will release first-quarter fiscal year 2021 financial results after the stock market closes on Tuesday, Feb. 16. The company will host a live webcast of its
Partners in Primary Care Announces 2021 Growth Plans for Its Senior-Focused Care Facilities
Partners in Primary Care announced today the details of its 2021 expansion. Having opened 15 new centers in 2020, plans for 2021 include up to 20 more centers, including entering the Atlanta
Illumina to Announce Fourth Quarter & Full Year 2020 Financial Results on Thursday, February 11, 2021
Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for the fourth quarter and full year 2020 following the close of market on Thursday, February 11, 2021.
On the same day, at
Agilent Announces Enhanced Mass Spectrometry and Automation Software Solutions to Support Regulatory Compliance Guidelines
Agilent Technologies Inc. (NYSE: A) today announced the release of MassHunter Workstation Plus 11.0, MassHunter Networked Workstation 11.0, and MassHunter BioConfirm. The latest revision of these
Pfizer and BioNTech Reach Agreement with COVAX for Advance Purchase of Vaccine to Help Combat COVID-19
Pfizer and BioNTech SE today announced an advance purchase agreement with COVAX for up to 40 million doses of the Pfizer-BioNTech COVID-19 Vaccine. The doses will be delivered throughout 2021.
Illumina Wins Patent Infringement Suit against BGI in the UK
Illumina, Inc. (NASDAQ: ILMN) today announced that the High Court of Justice, Chancery Division, Patents Court, issued a judgment in its favor in the patent infringement suit filed against the BGI
Dexcom Schedules Fourth Quarter and Full Year 2020 Earnings Release and Conference Call for February 11, 2021 at 4:30 p.m. Eastern Time
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and full year 2020 financial results after market close on Thursday, February 11, 2020. Management will hold a
Agilent Names Allison Ballmer Senior Vice President of Strategy and Corporate Development
Agilent Technologies Inc.(NYSE: A) is pleased to announce Allison Ballmer has been named the company’s new senior vice president of Strategy and Corporate Development, reporting to Agilent
Pfizer’s XALKORI® (crizotinib) Approved by FDA for ALK-positive Anaplastic Large Cell Lymphoma in Children and Young Adults
Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for XALKORI® (crizotinib) for the treatment of
Humana Healthy Horizons and The Humana Foundation Commit More Than $2.5 Million to COVID-19 Relief in Texas
Humana Healthy Horizons, the Medicaid business of Humana Inc. (NYSE: HUM), and Humana’s philanthropic arm, The Humana Foundation, have announced a more than $2.5 million commitment to COVID-19
PerkinElmer SARS-CoV-2 RT-PCR Assay Receives FDA EUA for Asymptomatic Testing
PerkinElmer, Inc. (NYSE:PKI) announced today that its PerkinElmer® New Coronavirus Nucleic Acid Detection Kit received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration
Veeva wird die erste Aktiengesellschaft, die in eine gemeinnützige Gesellschaft umgewandelt wird
Veeva Systems (NYSE: VEEV) gab bekannt, dass 99 % der stimmberechtigten Aktionäre mit überwältigender Mehrheit den Vorschlag des Unternehmens unterstützen, eine gemeinnützige Gesellschaft (PBC) zu
Veeva Becomes First Public Company to Convert to a Public Benefit Corporation
Veeva Systems (NYSE: VEEV) announced that in an overwhelming majority vote, 99% of voting shareholders support the company’s proposal to become a public benefit corporation (PBC), including the